Diabetic neuropathy in Mauritius: Prevalence and risk factors

Diabetes Research and Clinical Practice

Volumn 42, Issue 2, 1998, Pages 131-139

  Shaw, Jonathan E ^a   Hodge, Allison M ^a   De Courten, Maximilian ^a   Dowse, Gary K ^a   Gareeboo, Hassam ^b   Tuomilehto, Jaakko ^c   Alberti, K George M M ^d   Zimmet, Paul Z ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b Ministry of Health   (Mauritius)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Diabetic neuropathy; Lower extremity amputation; Population study; Type 2 diabetes; Vibration perception threshold

Indexed keywords

ADULT; ARTICLE; DIABETIC NEUROPATHY; FEMALE; GLUCOSE INTOLERANCE; HEALTH SURVEY; HUMAN; INSULIN BLOOD LEVEL; LEG AMPUTATION; MALE; MAURITIUS; MEDICAL ASSESSMENT; NEUROLOGIC EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; TOE; VIBRATION SENSE;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DIABETIC NEUROPATHIES; FEMALE; HUMANS; MALE; MAURITIUS; MIDDLE AGED; PREVALENCE; RISK FACTORS; SENSORY THRESHOLDS; VIBRATION;

EID: 0031772369     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(98)00100-4     Document Type: Article

References (28)

1. Tesfaye S., Stevens L.K., Stephenson J.M.et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM complications study. Diabetologia. 39:1996;1377-1384.
2. Young M.J., Boulton A.J.M., MacLeod A.F., Williams D.R.R., Sonksen P.H. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 36:1993;150-154.
3. Fedele D., Comi G., Coscelli C. A multicenter study on the prevalence of neuropathy in Italy. Diabet. Care. 20:1997;836-843.
4. Franklin G.M., Shetterly S.M., Cohen J.A., Baxter J., Hamman R.F. Risk factors for distal symmetric neuropathy in NIDDM. Diabet. Care. 17:1994;1172-1177.
5. Adler A., Boyko E.J., Ahroni J.H., Stensel V., Forsberg R.C., Smith D.G. Risk factors for diabetic peripheral neuropathy. Diabet. Care. 20:1997;1162-1167.
6. Nelson R.G., Gohdes D.M., Everhart J.E.et al. Lower-extremity amputations in NIDDM: 12-year follow-up study in Pima Indians. Diabet. Care. 11:1988;8-16.
7. Rith-Najarian S.J., Stolusky T., Ghodes D.M. Identifying diabetic patients at high risk for lower-extremity amputation in a primary care setting. Diabet. Care. 15:1992;13861389.
8. Forrest K.Y., Maser R.E., Pambianco G., Becker D.J., Orchard T.J. Hypertension as a risk factor for diabetic neuropathy. Diabetes. 46:1997;665-670.
9. Partanen J., Niskanen L., Lehtinen J., Mervaala E., Siitonen O., Uusitupa M. Natural history of peripheral neuropathy in patients with non-insulin dependent diabetes mellitus. New Engl. J. Med. 333:1995;89-94.
10. Dowse G.K., Gareeboo H., Zimmet et al. P.Z. High prevalence of NIDDM and impaired glucose tolerance in Indian, Creole and Chinese Mauritians. Diabetes. 39:1990;390-396.
11. Hodge A.M., Dowse G.K., Zimmet et al P.Z. Factors associated with impaired vibration perception in Mauritians with normal and abnormal glucose tolerance. J. Diabet. Complications. 9:1995;149-157.
12. Dowse G.K., Gareeboo H., Alberti et al K.G.M.M. Changes in population cholesterol concentration and other cardiovascular risk factor levels after five years of the noncommunicable disease intervention programme in Mauritius. Br. Med. J. 311:1995;1255-1259.
13. World Health Organization, Diabetes Mellitus: Report of a WHO Study Group. WHO, Geneva, Tech. Rep. Ser. no. 727, 1985.
14. Diabetic Retinopathy Study Research Group Report 7, A modification of the Airlie House classification of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 21 (1981) 210-226.
15. Soeldner J.S., Slone D. Critical variables in radioimmunoassay of serum insulin using the double antibody technique. Diabetes. 14:1965;771-779.
16. M.I. Harris, Classification, diagnostic criteria, and screening for diabetes, in: National Diabetes Data Group (Eds.), Diabetes in America, 2nd ed. National Institutes of Health and Digestive and Kidney Diseases, Bethesda MD (NIH publ. no. 95-1468), 1995, p. 15-36.
17. Young M.J., Breddy J.L., Veves A., Boulton A.J.M. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabet. Care. 17:1994;557-560.
18. Wiles P.G., Pearce S.M., Rice P.J., Mitchell J.M. Vibration perception threshold: influence of age, height, sex, and smoking, and calculation of accurate centile values. Diabet. Med. 8:1991;157-161.
19. Bloom S., Till S., Sonksen P., Smith S. Use of a biothesiometer to measure individual vibration thresholds and their variation in 519 non-diabetic subjects. Br. Med. J. 288:1984;1793-1795.
20. Walters D.P., Gatting W., Mullee M.A., Hill R.D. The prevalence of diabetic distal sensory neuropathy in an English community. Diabet. Med. 9:1992;349-353.
21. Neil H.A., Thompson A.V., Thorogood M., Fowler G.H., Mann J.I. Diabetes in the elderly: the Oxford Community Diabetes Study. Diabet. Med. 6:1989;608-613.
22. Kumar S., Ashe H.A., Parnell et al L.N. The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population-based study. Diabet. Med. 11:1994;480-484.
23. Borssen B., Bergenheim T., Lithner F. The epidemiology of foot lesions in diabetic patients aged 15-50 years. Diabet. Med. 7:1990;438-444.
24. Lee J.S., Lu M., Lee V.S., Russell D., Bahr C., Lee E.T. Lower-extremity amputation. Incidence, risk factors, and mortality in the Oklahoma Indian Diabetes Study. Diabetes. 42:1993;876-882.
25. Freeman W.L., Hosey G.M. Diabetic complications among American Indians of Washington, Oregon and Idaho. Diabetes Care. 16:1993;357-360.
26. Savage S., Estacio R.O., Jeffers B., Schrier R.W. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy and cardiovascular disease in NIDDM. Diabet. Care. 19:1996;1243-1248.
27. Ido Y., Vindigni A., Chang et al K. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science. 277:1997;563-566.
28. Sands M.L., Shetterly S.M., Franklin G.M., Hamman R.F. Incidence of distal symmetric (sensory) neuropathy in NIDDM. Diabet. Care. 20:1997;322-329.